High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma
Abstract Background Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the first rate-limiting enzyme of the hexosamine biosynthesis pathway (HBP), which plays a pivotal role in the progression of pancreatic ductal adenocarcinoma (PDAC). Therefore, we investigated the prognostic significance o...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2021-01-01
|
| Seria: | World Journal of Surgical Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s12957-021-02147-z |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|